Literature DB >> 15331626

Constitutive membrane expression of proteinase 3 (PR3) and neutrophil activation by anti-PR3 antibodies.

André P van Rossum1, Agnieszka A Rarok, Minke G Huitema, Giorgio Fassina, Pieter C Limburg, Cees G M Kallenberg.   

Abstract

Antineutrophil cytoplasm autoantibodies with specificity for proteinase 3 (PR3) are thought to play a major role in the pathogenesis of Wegener's granulomatosis (WG), presumably by their potential to activate neutrophils. In patients with WG, high expression of PR3 on the surface of nonprimed neutrophils is associated with an increased incidence and rate of relapse. In this study, we analyzed the functional significance of constitutive PR3 expression for neutrophil activation as induced by anti-PR3 antibody. Therefore, primed and nonprimed neutrophils were stimulated with the monoclonal anti-PR3 antibody PR3G-3. Activation was measured as actin polymerization by the phalloidin assay as an early, detectable activation event and oxidative burst by the dihydrorhodamine assay, as a late, detectable activation event. In contrast to the oxidative burst, we found that anti-PR3 antibody-induced actin polymerization could be triggered in neutrophils without priming with tumor necrosis factor alpha (TNF-alpha). In addition, a correlation was found between the level of PR3 expression on the surface of these nonprimed neutrophils and the degree of actin polymerization. However, after priming with TNF-alpha, no correlation was found between membrane expression of PR3 and the level of actin polymerization or respiratory burst as induced by anti-PR3 antibody. These data suggest that the presence of PR3 on the surface of nonprimed neutrophils has consequences for their susceptibility to the initial activation step by anti-PR3 antibodies. These data may be relevant in view of the observed relation between membrane expression of PR3 on nonprimed neutrophils of patients with WG and their susceptibility for relapses.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15331626     DOI: 10.1189/jlb.0604319

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  10 in total

Review 1.  Endothelium-neutrophil interactions in ANCA-associated diseases.

Authors:  Lise Halbwachs; Philippe Lesavre
Journal:  J Am Soc Nephrol       Date:  2012-09       Impact factor: 10.121

2.  IgG glycan hydrolysis attenuates ANCA-mediated glomerulonephritis.

Authors:  Mirjan M van Timmeren; Betty S van der Veen; Coen A Stegeman; Arjen H Petersen; Thomas Hellmark; Mattias Collin; Peter Heeringa
Journal:  J Am Soc Nephrol       Date:  2010-05-06       Impact factor: 10.121

3.  Circulating ADAM17 Level Reflects Disease Activity in Proteinase-3 ANCA-Associated Vasculitis.

Authors:  Anna Bertram; Svjetlana Lovric; Alissa Engel; Michaela Beese; Kristin Wyss; Barbara Hertel; Joon-Keun Park; Jan U Becker; Johanna Kegel; Hermann Haller; Marion Haubitz; Torsten Kirsch
Journal:  J Am Soc Nephrol       Date:  2015-03-18       Impact factor: 10.121

Review 4.  Mechanisms of vascular damage in ANCA vasculitis.

Authors:  David Massicotte-Azarniouch; Carolina A Herrera; J Charles Jennette; Ronald J Falk; Meghan E Free
Journal:  Semin Immunopathol       Date:  2022-03-07       Impact factor: 11.759

Review 5.  Neutrophil proteinase 3 and dipeptidyl peptidase I (cathepsin C) as pharmacological targets in granulomatosis with polyangiitis (Wegener granulomatosis).

Authors:  Brice Korkmaz; Adam Lesner; Stephanie Letast; Yassir K Mahdi; Marie-Lise Jourdan; Sandrine Dallet-Choisy; Sylvain Marchand-Adam; Christine Kellenberger; Marie-Claude Viaud-Massuard; Dieter E Jenne; Francis Gauthier
Journal:  Semin Immunopathol       Date:  2013-02-06       Impact factor: 9.623

6.  Catalytic activity and inhibition of wegener antigen proteinase 3 on the cell surface of human polymorphonuclear neutrophils.

Authors:  Brice Korkmaz; Jérôme Jaillet; Marie-Lise Jourdan; Alexandre Gauthier; Francis Gauthier; Sylvie Attucci
Journal:  J Biol Chem       Date:  2009-05-15       Impact factor: 5.157

Review 7.  Wegener's granulomatosis: a model of auto-antibodies in mucosal autoimmunity.

Authors:  James M Kelley; Jeffrey C Edberg; Robert P Kimberly
Journal:  Clin Immunol       Date:  2009-05-23       Impact factor: 3.969

8.  Standardised assessment of membrane proteinase 3 expression. Analysis in ANCA-associated vasculitis and controls.

Authors:  André P van Rossum; Minke G Huitema; Coen A Stegeman; Marc Bijl; Karina de Leeuw; Miek A Van Leeuwen; Pieter C Limburg; Cees G M Kallenberg
Journal:  Ann Rheum Dis       Date:  2007-04-19       Impact factor: 19.103

9.  Elevated soluble Flt1 inhibits endothelial repair in PR3-ANCA-associated vasculitis.

Authors:  Sandrine Le Roux; Ruth J Pepper; Alexandre Dufay; Mélanie Néel; Emmanuelle Meffray; Noël Lamandé; Marie Rimbert; Régis Josien; Mohamed Hamidou; Maryvonne Hourmant; H Terence Cook; Béatrice Charreau; Etienne Larger; Alan D Salama; Fadi Fakhouri
Journal:  J Am Soc Nephrol       Date:  2011-10-27       Impact factor: 10.121

Review 10.  Pathogenicity of Proteinase 3-Anti-Neutrophil Cytoplasmic Antibody in Granulomatosis With Polyangiitis: Implications as Biomarker and Future Therapies.

Authors:  Jérôme Granel; Brice Korkmaz; Dalila Nouar; Stefanie A I Weiss; Dieter E Jenne; Roxane Lemoine; Cyrille Hoarau
Journal:  Front Immunol       Date:  2021-02-18       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.